|Articles|December 1, 2015
- BioPharm International-12-01-2015
- Volume 28
- Issue 12
BioPharm International, December 2015 Issue (PDF)
Click the title above to open the BioPharm International December 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Bespoke Bioprocessing Resinsabout 10 years ago
New Drugs and New Initiatives Shaped 2015about 10 years ago
CMO Investors Have More Money Than Places to Spend Itabout 10 years ago
Rapid Mycoplasma Testing: Meeting the Burden of Proofabout 10 years ago
N-Glycan Composition Profiling for Quality Testing of Biotherapeuticsabout 10 years ago
Greener Pastures in Biologics?about 10 years ago
GMP Challenges for Advanced Therapy Medicinal ProductsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
